Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate

The Journal of Rheumatology
Gurjit S KaeleyVeena K Ranganath

Abstract

Obese patients with rheumatoid arthritis (RA) report more joint swelling and tenderness and often have poorer responses to therapy than nonobese patients. The aim of this posthoc analysis of the MUSICA trial was to compare imaging and clinical disease activity measures in obese and nonobese patients with RA. MUSICA evaluated methotrexate (MTX) 20 mg/week versus 7.5 mg/week in combination with adalimumab (ADA) in RA patients with an inadequate response to MTX. Patients were categorized by baseline body mass index as normal (< 25), overweight (≥ 25 to < 30), or obese (≥ 30). Synovial vascularity and hypertrophy, swollen and tender joint counts (SJC and TJC), American College of Rheumatology (ACR) responses, and low disease activity (LDA), defined as Clinical Disease Activity Index < 10 and 28-joint count Disease Activity Score using C-reactive protein (DAS28-CRP) < 3.2, were assessed at weeks 12 and 24. Patient characteristics were similar among groups at baseline. Obese patients had numerically smaller changes from baseline to weeks 12/24 in SJC, TJC, DAS28-CRP, and synovial hypertrophy and vascularity versus nonobese patients. Significantly fewer obese patients reached ACR20/50 at weeks 12 and 24, and LDA at Week 12; this diffe...Continue Reading

References

Nov 6, 1998·British Journal of Clinical Pharmacology·C GodfreyJ Kremer
Jun 19, 2001·Annals of the Rheumatic Diseases·M BackhausUNKNOWN Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International Clinical Studies including The
Jun 18, 2005·The Proceedings of the Nutrition Society·Hans Hauner
Mar 6, 2007·The Journal of Pain : Official Journal of the American Pain Society·Holli C HittArthur G Cosby
Oct 31, 2007·Arthritis and Rheumatism·Gisela WesthoffAngela Zink
Feb 23, 2010·Current Directions in Autoimmunity·T TzanavariKatia P Karalis
Feb 1, 2011·Arthritis and Rheumatism·Ruth KlaasenPaul P Tak
Feb 8, 2011·Lancet·Mariel M FinucaneUNKNOWN Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index)
Feb 22, 2011·Arthritis and Rheumatism·E NeumannU Müller-Ladner
Apr 9, 2011·Rheumatology International·Francesco UrsiniRosa Daniela Grembiale
Apr 7, 2012·Molecular and Cellular Endocrinology·Caroline Candida DeOliveiraAlessandra Gambero
Jun 26, 2012·Arthritis Care & Research·Elisa GremeseUNKNOWN Gruppo Italiano di Studio sulle Early Arthritis (GISEA)
Dec 12, 2012·Therapeutic Advances in Musculoskeletal Disease·Taeyoung KangRichard J Wakefield
Sep 18, 2013·Diabetes, Obesity & Metabolism·A W Ferrante
Jul 10, 2014·The Journal of Endocrinology·Milos Mraz, Martin Haluzik
Aug 6, 2014·Annals of the Rheumatic Diseases·Joshua F BakerPhilip G Conaghan
Sep 17, 2014·British Journal of Clinical Pharmacology·David TernantGilles Paintaud
Nov 27, 2014·Frontiers in Immunology·Elisa GremeseGianfranco Ferraccioli
Dec 15, 2015·European Journal of Gastroenterology & Hepatology·Ashley BondSreedhar Subramanian
Mar 6, 2017·BMC Musculoskeletal Disorders·Erin M BauerVeena K Ranganath
Apr 11, 2017·Arthritis Care & Research·Michael D GeorgeJoshua F Baker
Jun 24, 2017·Metabolism: Clinical and Experimental·Dylan Thomas, Caroline Apovian

❮ Previous
Next ❯

Citations

Jul 18, 2019·The New England Journal of Medicine·Zhiwei ChenShuang Ye
Aug 3, 2020·Current Rheumatology Reports·Dilli PoudelJoshua F Baker
Feb 6, 2020·Clinical Rheumatology·Luca MoroniLorenzo Dagna
Apr 2, 2021·Open Access Rheumatology : Research and Reviews·Gianna EspinozaCarlos Rios

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.